» Articles » PMID: 36774529

Diagnostic Efficiency on Ultrasound Shear Wave Elastography in Evaluation of Steatosis Severity for Non-alcoholic Fatty Liver Disease: a Rat Model

Overview
Journal Eur J Med Res
Publisher Biomed Central
Specialty General Medicine
Date 2023 Feb 11
PMID 36774529
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The pathological feature of steatosis affects the elasticity values measured by shear wave elastography (SWE) is still controversial in non-alcoholic fatty liver disease (NAFLD). The aim of this study is to demonstrate the influence of steatosis on liver stiffness measured by SWE on a rat model with NAFLD and analyze feasibility of SWE for grading steatosis in absence of fibrosis.

Methods: Sixty-six rats were fed with methionine choline deficient diet or standard diet to produce various stages of steatosis; 48 rats were available for final analysis. Rats underwent abdominal ultrasound SWE examination and pathological assessment. Liver histopathology was analyzed to assess the degree of steatosis, inflammation, ballooning, and fibrosis according to the non-alcoholic fatty liver disease activity score. The diagnostic performance of SWE for differentiating steatosis stages was estimated according to the receiver operating characteristic (ROC) curve. Decision curve analysis (DCA) was conducted to determine clinical usefulness and the areas under DCA (AUDCAs) calculated.

Results: In multivariate analysis, steatosis was an independent factor affecting the mean elastic modules (B = 1.558, P < 0.001), but not inflammation (B =  - 0.031, P = 0.920) and ballooning (B = 0.216, P = 0.458). After adjusting for inflammation and ballooning, the AUROC of the mean elasticity for identifying S ≥ S1 was 0.956 (95%CI: 0.872-0.998) and the AUDCA, 0.621. The AUROC for distinguishing S ≥ S2 and S = S3 was 0.987 (95%CI: 0.951-1.000) and 0.920 (95%CI: 0.816-0.986) and the AUDCA was 0.506 and 0.256, respectively.

Conclusions: Steatosis is associated with liver stiffness and SWE may have the feasibility to be introduced as an assistive technology in grading steatosis for patients with NAFLD in absence of fibrosis.

Citing Articles

NO-IL-6/10-IL-1β axis: a new pathway in steatotic and non-steatotic liver grafts from brain-dead donor rats.

Casillas-Ramirez A, Mico-Carnero M, Sanchez-Gonzalez A, Maroto-Serrat C, Trostchansky A, Peralta C Front Immunol. 2023; 14:1178909.

PMID: 37593740 PMC: 10427871. DOI: 10.3389/fimmu.2023.1178909.

References
1.
Huang Z, Zhou J, Lu X, Zhang T, Xu S, Jin J . How does liver steatosis affect diagnostic performance of 2D-SWE.SSI: assessment from aspects of steatosis degree and pathological types. Eur Radiol. 2020; 31(5):3207-3215. DOI: 10.1007/s00330-020-07288-5. View

2.
Gatos I, Drazinos P, Yarmenitis S, Theotokas I, Koskinas J, Koullias E . Liver Ultrasound Attenuation: An Ultrasound Attenuation Index for Liver Steatosis Assessment. Ultrasound Q. 2022; 38(2):124-132. DOI: 10.1097/RUQ.0000000000000605. View

3.
Dietrich C, Bamber J, Berzigotti A, Bota S, Cantisani V, Castera L . EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version). Ultraschall Med. 2017; 38(4):e16-e47. DOI: 10.1055/s-0043-103952. View

4.
de Almeida E Borges V, Diniz A, Cotrim H, Rocha H, Andrade N . Sonographic hepatorenal ratio: a noninvasive method to diagnose nonalcoholic steatosis. J Clin Ultrasound. 2012; 41(1):18-25. DOI: 10.1002/jcu.21994. View

5.
Takeuchi H, Sugimoto K, Oshiro H, Iwatsuka K, Kono S, Yoshimasu Y . Liver fibrosis: noninvasive assessment using supersonic shear imaging and FIB4 index in patients with non-alcoholic fatty liver disease. J Med Ultrason (2001). 2017; 45(2):243-249. DOI: 10.1007/s10396-017-0840-3. View